Suncrest debuts HangRx/p-link will-call system
OREM, Utah — Suncrest Solutions in partnership with EZ-RFID introduced the HangRx/p-link automated light guided will-call system.
Using radio frequency ID, this patented system easily converts existing the hangup bag will call system to a highly efficient, automated light guided will call, a win-win for pharmacists and patients, according to the company. “With integrations and relationships in today’s top pharmacy management systems, upgrading your will call doesn’t get any easier,” stated Suncrest.
“The technology has thus far been implemented at Drugco Discount Pharmacy in Roanoke Rapids, N.C. “The system provides a huge amount of [return on investment] for both money and time,” said Drew Huggins, chief operating officer for Drugco. “Our pharmacy fills 1,300 prescriptions per day and has over 600 individual prescription pick-ups on a typical day. If we are conservatively saving an average of 1 minute per prescription pick up, we are recouping almost 10 hours of employee time per day in retrieving prescriptions alone. Our cost savings are primarily associated with this reduction in employee time burden, as well as a decrease in costs associated with prescription pick-up errors and lost time for long searches.”
Great Product with great early reviews coming in! So excited to be apart of it!
Innovation to offer Advanced Pharmacy Practice Experience to Binghamton students
BINGHAMTON, N.Y. — Innovation will provide Advanced Pharmacy Practice Experience to students enrolled in the Binghamton University School of Pharmacy & Pharmaceutical Sciences beginning with the fall class of 2017.
“We’re honored to become an advanced pharmacy practice site and to offer Binghamton University pharmacy students the opportunity to learn about the many complexities of today’s ever-evolving pharmacy operations. This is a unique APPE offering for students that truly differentiates Binghamton University SOPPS from schools of pharmacy around the country,” said Phil Samples, PharmD, VP, professional and government service at Innovation and a member of the new school’s Dean’s Advisory Council. “We’re looking forward to sharing our in-depth knowledge and experiences with [Binghamton] students, and we’re dedicated to helping them prepare for their careers in pharmacy and for improving patient outcomes.”
Binghamton students that select this elective rotation will spend six weeks working side-by-side with Innovation senior team members with a specific focus on learning effective management and leadership skills in an outpatient pharmacy operations environment. In addition, students will learn proven best practice tools and techniques to analyze, interpret, model, simulate, and predict operational performance under relevant workload, workflow, and process options. Lastly, Innovation, makers of PharmASSIST pharmacy automation solutions, will teach students about Lean Six Sigma and how to apply the methodology to pharmacy operations.
“By exposing our prospective pharmacists to the future of pharmacy, our students will be both well versed in the various technological advancements in today’s pharmacies, and be immersed in problem-solving methodology that can be applied to critically assessing patients,” said Angela Riley, PharmD, CGP, assistant dean, experiential education at Binghamton University.
“Innovation has created strong relationships with various schools from Binghamton University to develop Pharmacy Intelligence to improve outcomes in pharmacy practice,” she added. “The next best step is to create a strong relationship with the SOPPS, as these students will be the practitioners implementing and managing such technological advancement. I look forward to growing with Innovation.”
Binghamton University’s School of Pharmacy and Pharmaceutical Sciences will begin on Binghamton’s campus in August 2017, and will eventually relocate to a newly constructed building on a new, eight-acre health sciences campus in Johnson City, N.Y. The new building is expected to open in 2018.
No comments found
CVS to offer discounts on certain medications to its patients
WOONSOCKET, R.I. — CVS Health will launch Reduced Rx, a prescription savings program that will offer discounts on certain medications through CVS Health's pharmacy benefits manager, CVS Caremark directly to patients. The program will help patients with high out of pocket costs afford essential medications.
Novo Nordisk will participate in the prescription savings program. Through this program, CVS Health and Novo Nordisk will offer Novolin R, Novolin N and Novolin 70/30 human insulin at a cost of $25 per 10ml vial, which reflects a potential savings of as much as $100 for cash paying patients.
"We developed the Reduced Rx prescription savings program with Novo Nordisk because we both recognized a need and an opportunity to make critical medications more affordable for patients," said Jonathan Roberts, EVP and Chief Operating Officer, CVS Health. "This savings program will leverage CVS Caremark's expertise in providing lower cost prescription drugs and fulfill our company's purpose of helping people on their path to better health."
The Reduced Rx launch follows another affordability announcement made earlier this year by CVS Health. Working with Impax Laboratories, CVS Health announced in January that it has made the authorized generic for Adrenaclick, an epinephrine auto-injector for patients with allergic reactions, available at all CVS Pharmacy locations at the lowest cash price in the market, $109.99 for a two-pack. CVS Health collaborated to create both the generic Adrenaclick offering and the Reduced Rx program in response to consumer need for low cost options.
"This program underscores how important collaboration is to addressing the affordability challenges patients face in certain health plans or who remain uninsured. We all have a role to play and that's why we welcomed the chance to work with CVS Health on this program," said Doug Langa, SVP and head of North America Operations, Novo Nordisk. "We're committed to developing sustainable solutions with customers and will continue to pursue opportunities to ensure that patients have access to insulin that is affordable."
Reduced Rx will allow patients to purchase medications at a reduced cost at any of the more than 67,000 pharmacies in the CVS Caremark retail network, including the more than 9,700 CVS Pharmacy locations throughout the U.S. Patients using the Reduced Rx prescription savings program will need to pay the cost of the medication out of pocket; the program cannot be used with any prescription drug insurance coverage.
"With nearly 10% of the U.S. population living with diabetes, ensuring patients have access to affordable insulin is more important than ever," said Troyen Brennan, M.D., Executive Vice President and Chief Medical Officer, CVS Health. "We're pleased that our Reduced Rx prescription savings program can help assure that effective medications are also affordable."
No comments found